Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by NgamiaSwedeon Jul 04, 2014 12:02am

215 Views

Post# 22715270

RE:RE:100% matching in all mammal

bencro,
Thanks, the more we know the better Q we can ask in time. For me it is all about learning and figure out the %/odds off success.
If you translate this from Swedish

"Telomerer sitter i änden på varje kromosom, som ett skyddande lock för att kromosomens information inte ska skadas och skapa förvirring i cellmaskineriet. Telomerna består av en upprepad DNA-sekvens, TTAGGG, som är exakt lika hos alla däggdjur"

And here is the link

https://www.umu.se/forskning/popularvetenskap/forskarportratt/goran-roos/

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages